ACI London Thrombectomy in STEMI. is the evidence clear? Brad Higginson International marketing manager

Similar documents
Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam

Journal of the American College of Cardiology Vol. 56, No. 16, by the American College of Cardiology Foundation ISSN /$36.

Revived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS

Trial Update- TOTAL. Jonathan Byrne

ΟΜΑΔΕΣ ΕΡΓΑΣΙΑΣ ΘΕΣ/ΝΙΚΗ 2013

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

Updated and Guideline Based Treatment of Patients with STEMI

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

For Personal Use. Copyright HMP 2013

Thrombectomy. how? For whom?

Therapeutic Advances in Cardiology

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Cindy L. Grines MD FACC FSCAI

PCI Update Qesaria 2009

Protection of side branch is essential in treating bifurcation lesions: overview

No-reflow is defined as a failure to restore antegrade normal coronary flow despite appropriate treatment of coronary obstruction. The prevalence of t

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

PROMUS Element Experience In AMC

Primary Percutaneous Coronary Intervention

STEMI Primary Percutaneous Coronary Intervention

Every heartbeat is precious. Thanks to you, he ll have 100 million more.

Cafri C; Zahger D; Rosenshtein G, Kleshian I; Ilia R

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

Case Report Rheolytic Thrombectomy Combined with a Protective Filter and Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Rescue Angioplasty

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

Béla MERKELY MD, PhD, DSc, FESC. Stent thrombosis: patophysiology, predisposing factors, definition, classification, prevention and treatment

Quale terapia antiaggregante nello STEMI? Prasugrel vs ticagrelor

New Generation Drug- Eluting Stent in Korea

Stent Thrombosis in Bifurcation Stenting

What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN

The Tryton Side Branch System in Distal Left Main PCI

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Percutaneous coronary intervention. Original Research

Clinical Considerations for CTO

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

TCT mdbuyline.com Clinical Trial Results Summary

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Side Branch Occlusion

Direct Thrombin Inhibitors for PCI Pharmacology: Role of Bivalirudin in High-Risk PCI

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo

Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy

Cover Page. The handle holds various files of this Leiden University dissertation

Clopidogrel vs New Antiplatelet Therapy (Prasugrel) Adnan Kastrati, MD Deutsches Herzzentrum, Technische Universität München, Germany

Primary PCI in STEMI: The Role of Thromboaspiration

PCI for In-Stent Restenosis. CardioVascular Research Foundation

FFR-guided Jailed Side Branch Intervention

Post PCI functional testing and imaging: case based lessons from FFR React

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI

Coronary angiography and PCI

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve

Frans Van de Werf, MD, PhD Leuven, Belgium

CARDIOLOGY SYMPOSIUM 2015 CAROLINA CARDIOLOGY CONSULTANTS OF GHS

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention

Meet the Guidelines Le principali novità che modificheranno la nostra pratica clinica: STEMI

DESolve NX Trial Clinical and Imaging Results

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

Approach to Multi Vessel disease with STEMI

The role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel

Antiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology

Lessons learned From The National PCI Registry

Late stent thrombosis: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESc Institute of Cardiology Catholic University of Rome, Italy

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Myocardial Infarction In Dr.Yahya Kiwan

Overview of Trasradial Approach for Coronary Angiography and Intervention. A/Prof. Phạm Mạnh Hùng, MD.FACC., FESC

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

Primary PCI in patients with STEMI Abbott Vascular. All rights reserved.

Presented by Prof David Erlinge, MD, PhD, On behalf of the RAPID MI-ICE Investigators

Danish registry of ACS DANAMI Studies Peter Clemmensen, MD, DMSc, FESC, FSCAI Thomas Engstrøm, MD, PhD, DMSc

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital

Primary PCI State of the Art. A/Prof Michael Nguyen Fremantle Hospital/Fiona Stanley Hospital Perth Australia JCR Meeting Busan 2014

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

CPT Code Details

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea

DOUBLE or TRIPLE ANTI-TROMBOTIC THERAPY in ACS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands

Stent Trials in Acute Myocardial Infarction

When and how to combine antiplatelet agents and anticoagulant?

Methods of Thrombus Fragmentation & Extraction. Methods of Thrombus Extraction

CTO Re vascularization in 2013

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS

New insights in stent thrombosis: Platelet function monitoring. Franz-Josef Neumann Herz-Zentrum Bad Krozingen

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

Statistical analysis plan

DAPT Management 2015 Michael Rinaldi, MD

From STEMIs to Stents: Updates in PCI practice

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

LM stenting - Cypher

CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Transcription:

ACI London 2010 Thrombectomy in STEMI is the evidence clear? Brad Higginson International marketing manager

Options for Management of Thrombotic Lesions Pharmacologic Therapies Embolic Protection Devices Filters Balloon Occlusion Mechanical Thrombectomy Devices Rheolytic thrombectomy (AngioJet) Aspiration Thrombectomy Devices Dr. Bruce Brodie LeBauer Heart, North Carolina

AngioJet history Over ½ million treated WW Cumulative Catheters Sold 500,000 6,53815,238 31,19656,586 132,610 89,993 184,582 233,859 280,640 352,475 327,981 422,745 FY98 FY99 FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY 2010

AngioJet technology review

CFD analysis mechanical vs aspiration

OCT aspiration vs mechanical thrombectomy

Practice guidelines and devices

Is a Class 1, Level A guideline attainable? Challenging the Class one distinction? TAPAS Bias between treatment arms AiMI AngioJet in Myocardial Infarction Mortality endpoint TIMI 3 flow baseline imbalance between treatment arms

TAPAS New England Journal of Medicine (NEJM)

TAPAS NEJM Conclusion Thrombus aspiration is applicable in a large majority of patients with myocardial infarction with ST-segment elevation, and it results in better reperfusion and clinical outcomes than conventional PCI, irrespective of clinical and angiographic characteristics at baseline.

TAPAS NEJM, respective caveats Small thrombus burden 49% 44% Thrombectomy was primary procedure 90% Predilation was primary procedure 00% 96%

New England Journal of Medicine Dr. Vetrovec editorial

NEJM technique editorial Dr. Vetrovec summarized Some operators believe that direct stenting without multiple balloon inflations reduces the risk of distal emboli. The majority of patients in the conventional-pci group had balloon angioplasty followed by stenting, which might have increased the relative incidence of embolization in the conventional-pci group.

AiMI not our best effort

30 Day MACE 10 Angiojet Control n=240 n=240 8 6 4 P=0.02 4.6% P=0.01 6.7% 2 0 0.8% 0% 0% 1.7% 0.8% 2.1% 0.4% 1.7% Death Q wave MI Stroke TLR Total

AngioJet for STEMI Cindy L. Grines, M.D. William Beaumont Hospital Royal Oak, Michigan

AiMI Control Arm Mortality is Far Lower than in the Meta-Analysis PCI Arm There is extremely low, p=0.0007, chance that a new PCI trial would observe mortality of 0.8% or less AiMI PCI Arm is an outlier, extreme observation, or in the tail, as compared to the body of PCI evidence (N=124 Study Arms)

Is a Class 1, Level A guideline attainable? Better science TAPAS 2 JETSTENT Thrombus caveats Large vs Small Fresh vs Organized Platelet rich versus Fibrin rich

Thrombus burden re-defined

Thrombus burden Harvard style

When to use DES in AMI Georgios Sianos, MD, PhD, FESC Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands

DES IRA Stent Thrombosis Independent predictor HR 95% CI P value Stent Thrombosis Presentation 4.1 1.39-12.09 0.01 bifurcational stenting 5.51 2.32-13.07 <0.001 Rheolytic Thrombectomy 0.12 0.02-0.86 0.036 Large Thrombus burden 6.95 2.99-16.2 <0.001

Large thrombus burden impact (LTB) eorgios Sianos, MD, PhD, FESC

JetStent JACC, 2010 LTB predictive!

LTB and JetStent study JACC 2010 Pts with STEMI admitted within 12 hours from symptom onset Lysis Stroke < 30 days Surgery < 6 weeks Pre-stented IRA After angiography and IRA wiring: thrombus grade 3 to 5 Randomization 1:1 N = 500 Rheolytic Thrombectomy + DS Direct Stenting (DS) Journal of the American College of Cardiology, Volume 56, Issue 16, 12 October 2010, Pages 1298-1306 Angela Migliorini, Amerigo Stabile, Alfredo E. Rodriguez, Caterina Gandolfo, Alfredo M. Rodriguez Granillo, Renato Valenti, Guido Parodi, Franz- Josef Neumann, Antonio Colombo, David Antoniucci and JETSTENT Trial Investigators

Predictors of ST-Segment Resolution and 1-Year MACE 30 min ST Reduction 50% OR 95%CI p value Randomization to RT 1.70 1.03 2.82.039 Anterior AMI 0.29 0.17 0.47 <.001 Final TIMI 3 flow 2.10 1.17-3.80.013 1-year MACE HR 95%CI p value Randomization to RT 0.50 0.31 0.82.006 Age (yrs) 1.02 1.01 1.04.023 Bleeding 4.33 1.80 10.42.001 Journal of the American College of Cardiology, Volume 56, Issue 16, 12 October 2010, Pages 1298-1306 Angela Migliorini, Amerigo Stabile, Alfredo E. Rodriguez, Caterina Gandolfo, Alfredo M. Rodriguez Granillo, Renato Valenti, Guido Parodi, Franz- Josef Neumann, Antonio Colombo, David Antoniucci and JETSTENT Trial Investigators

TCT 2010 symposium - publication Classify Thrombus Grade Balloon Predilation Discouraged Dual Thrombectomy Recommendation

STEMI protocol recommendation Aspiration AngioJet